Format

Send to

Choose Destination
BMC Infect Dis. 2015 Apr 11;15:180. doi: 10.1186/s12879-015-0916-x.

Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali.

Author information

1
Centre d'Infectiologie Charles Mérieux, Bamako, République du Mali. fatimtraorefaye@hotmail.fr.
2
Université de Lyon, UMRS 449 ; Laboratoire de Biologie générale, Université Catholique de Lyon ; Reproduction et développement comparé, EPHE, Lyon, France. egormally@univ-catholyon.fr.
3
International Agency for Research on Cancer, Lyon, France. villars@iarc.fr.
4
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA. mfriesen@jhsph.edu.
5
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA. jgroopma@jhsph.edu.
6
Laboratoire des Pathogènes Emergents Fondation Mérieux, Lyon, France. guy.vernet@hotmail.com.
7
Centre Pasteur du Cameroun, Yaoundé, Cameroun. guy.vernet@hotmail.com.
8
Centre d'Infectiologie Charles Mérieux, Bamako, République du Mali. souleymane.diallo@fondationmerieux-mali.org.
9
International Prevention Research Institute, Lyon, France. pierre.hainaut@i-pri.org.
10
Service de Gastroentérologie et Hépatologie, Centre Hospitalier Universitaire Gabriel Touré, Bamako, République du Mali. maigamoussay@yahoo.fr.

Abstract

BACKGROUND:

Hepatitis B (HB) infection is common in Mali. However, there is little information on molecular and biochemical characteristics of HB carriers.

METHODS:

A group of 1466 adult volunteers was recruited in the district of Bamako. Confirmed HB carriers were tested for HB viral load by quantitative PCR and HBV was genotyped by sequencing of HBS. Fibrosis and hepatitis activity were measured using the Fibrotest-Actitest. A mutation of TP53 at codon 249 (R249S), specific for exposure to aflatoxin, was detected in cell-free DNA extracted from plasma.

RESULTS:

Overall, 276 subjects were HBsAg-positive (18.8%). Among 152 subjects tested for HBV load, 49 (32.2%) had over 10(4) copies/mL and 16 (10.5%) had levels below the limit of detection. The E genotype was found in 91.1% of carriers. Fibrotest scores ≥ F2 were observed in 52 subjects (35.4%). Actitest scores ≥ A2 were detected in 15 subjects (10.2%) and were correlated with Fibrotest scores (p = 0.0006). Among 105 subjects tested, 60% had detectable levels of R249S copies (>40 copies/mL plasma).

CONCLUSION:

Chronic HB carriage in adults in Bamako district is well over epidemic threshold. About 1/3 of carriers have moderate to severe liver fibrosis and 60% have detectable aflatoxin-related TP53 R249S mutation. These results support introduction of anti-HB therapies to reduce the progression towards severe liver disease.

PMID:
25886382
PMCID:
PMC4403772
DOI:
10.1186/s12879-015-0916-x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center